Ovarian Cysts
Methodology & AI Transparency ⓘ
Ovarian Cysts Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: The ovaries are part of the female reproductive system.
- 2 Real-world patient consensus: Clinical coding for Ovarian Cysts uses ICD-10 E28.3 across OB/GYN & PCOS specialty care.
- 3 Typical cash cost range: Primary evaluation for Ovarian Cysts incorporates Rotterdam ovulatory/androgen criteria [Ovarian Cysts E28.3] and symptom diary review.
- 4 Top reported side effects / signs: Objective lab/clinical target for Ovarian Cysts: LH, FSH & in Ovarian Cysts (E28.3: Prolactin) (Normal ovulatory endocrine axis (E28.3)) and Free & Total in Ovarian Cysts (E28.3: Testosterone + SHBG).
Ask our AI Specialists anything about Ovarian Cysts
What Is Ovarian Cysts?
The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones . Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in ob/gyn & pcos, Ovarian Cysts (E28.3) involves pelvic peritoneal cytokine in Ovarian Cysts (E28.3: sensitization). Cross-referenced with NIH MeSH (Ovarian Cysts), progression correlates with shifts in LH, FSH & in Ovarian Cysts (E28.3: Prolactin) (Normal ovulatory endocrine axis (E28.3)).
Common Symptoms & Clinical Signs
- • Pain in the lower abdomen, on the side where the cyst is
- • Presentation of Ovarian Cysts (E28.3): pelvic pressure, bloating, in Ovarian Cysts (E28.3: or pain radiating)
- • Secondary Ovarian Cysts clinical sign: irregular, infrequent, or in Ovarian Cysts (E28.3: absent ovulatory menstrual)
- • Symptom flares in Ovarian Cysts correlating with LH, FSH & in Ovarian Cysts (E28.3: Prolactin) deviation outside Normal ovulatory endocrine axis (E28.3)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Ovarian Cysts Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E28.3 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | PCOS, Endometriosis & Gynecologic Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: LH, FSH & in Ovarian Cysts (E28.3: Prolactin) | Normal ovulatory endocrine axis (E28.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Free & Total in Ovarian Cysts (E28.3: Testosterone + SHBG) | Sex-specific physiological range (E28.3) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Fasting Insulin & in Ovarian Cysts (E28.3: HbA1c) | Fasting insulin < 8 uIU/mL (E28.3) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Ovarian Cysts
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Carboplatin Kyxata • RxCUI 597195 | Platinum-based Drug | 81% | $0.6200 | $ 33.61 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Ovarian Cysts)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Veliparib concomitant with first-line chemotherapy and as maintenance therapy in: What a 1,140-Participant Study Found No OS or DRS benefit of addition of veliparib to platinum-based chemotherapy and continued as maintenance therapy was detected in this study, despite an observed. European journal of cancer (Oxford, England : 1990) • 2025-07-25 • Phase III Randomized Trial | N = 1,140 | 96/100 | PMID 40561681 ↗ |
| New Insights on Impact of subclinical hypothyroidism on core reproductive hormones and ovarian: What a 3,114-Participant Study Found Current evidence shows no significant differences in FSH, LH, estradiol, or total testosterone levels between SCH and euthyroid PCOS controls, while the evidence for prolactin. Frontiers in endocrinology • 2026-01-15 • Meta-Analysis | N = 3,114 | 94/100 | PMID 42798498 ↗ |
| New Insights on Reproductive hormone characteristics of obese Chinese patients with polycystic: What a 4,554-Participant Study Found Conversely, they exhibited significantly higher testosterone (T) ( p = 0.001) levels. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology • 2025-12-15 • Meta-Analysis | N = 4,554 | 94/100 | PMID 40287875 ↗ |
| New Insights on Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women: What a 1,157-Participant Study Found Maintenance therapy with P and PP did not improve OS among patients with newly diagnosed O/tubal/peritoneal cancer, but may modestly increase PFS. Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2022-12-10 • Phase III Randomized Trial | N = 1,157 | 90/100 | PMID 35759733 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of intravenous administration of high-dose selenium for Intravenous high-dose selenium safely failed to reduce grade 1 or more CIPN, whereas it reduced grade 2 or more motor dysfunction during chemotherapy in patients with PSROC, especially those ≥ 60 years. BMC medicine • 2026-02-02 • Phase III Randomized Trial | N = 68 | 88/100 | PMID 41630017 ↗ |
Ovarian Cysts Patient Community & “People Like Me” Threads
Filter Ovarian Cysts community threads and patient logs by age, biological sex, dosage, and treatment duration.